uniQure (QURE) Gross Margin (2021 - 2026)

uniQure (QURE) recorded quarterly Gross Margin of 93.85% in Q1 2026, up 1.81% quarter-over-quarter from 92.19% in Q4 2025, and up 642.0% on a YoY basis from 12.65% in Q1 2025.

uniQure (QURE) Gross Margin (2021 - 2026) Analysis & Trends

uniQure's Gross Margin history runs 5 years deep, the most recent figure standing at 93.85% for Q1 2026.

  • In Q1 2026, Gross Margin rose 642.0% year-over-year to 93.85%; the TTM figure through Mar 2026 stood at 90.56% (down 294.0% YoY), while the FY2025 annual figure was 89.53%, down 580.0% from the prior year.
  • Gross Margin was 93.85% for Q1 2026 at uniQure, up from 92.19% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 100.43% in Q4 2022 to a low of 67.4% in Q2 2022.
  • Historically, Gross Margin has averaged 74.71% across 4 years, with a median of 88.85% in 2024.
  • The sharpest annual moves came in 2022 and 2026: Gross Margin sank 16241 bps in 2022, then surged 642 bps in 2026.
  • A 4-year view of Gross Margin shows it stood at 100.43% in 2022, then decreased by 12 bps to 88.14% in 2024, then advanced by 5 bps to 92.19% in 2025, then gained by 2 bps to 93.85% in 2026.
  • The last three Gross Margin figures came in at 93.85% (Q1 2026), 92.19% (Q4 2025), and 89.25% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 79.04%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 86.85%
9 Abivax 91.96 Bn 91.96 Bn - -
10 uniQure 2.88 Bn 2.88 Bn 3.34 Mn 93.85%

Historic Data

Download Data
DateValue
Mar 31, 2026 93.85%
Dec 31, 2025 92.19%
Sep 30, 2025 89.25%
Jun 30, 2025 87.53%
Mar 31, 2025 87.43%
Dec 31, 2024 88.14%
Sep 30, 2024 88.46%
Jun 30, 2024 97.90%
Mar 31, 2024 98.23%
Dec 31, 2022 100.43%
Sep 30, 2022 40.58%
Jun 30, 2022 -67.40%
Dec 31, 2021 96.88%
Sep 30, 2021 100.00%
Jun 30, 2021 95.00%